Encore Capital Group, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 4, 2026, reporting third-quarter and year-to-date financial results for the debt purchasing and servicing company.
Mineralys Therapeutics, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 4, 2026, reporting a nine-month net loss of $337.7 million and total assets of $630.1 million.
Mineralys Therapeutics, Inc. filed a Form 8-K on November 4, 2026, disclosing the resignation of board director Derek DiRocco, Ph.D., and reporting financial results for the quarter ended September 30, 2026.
Eagle Bancorp Montana, Inc. filed its quarterly report on Form 10-Q with the SEC on November 4, 2026, covering the fiscal quarter ended September 30, 2026, disclosing share count, filer status, and operational details for its Montana-focused community banking operations.
Datadog, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 4, 2026, disclosing balance sheet and capital structure data for the third quarter of fiscal year 2026.
BlackRock, Inc. filed a Schedule 13G with the SEC on November 4, 2026, disclosing beneficial ownership of 10,403,897 shares of common stock in Navient Holdings, Inc., representing 11.2% of the class, as of the event date of October 31, 2026.
McKesson Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 4, 2026, reporting results for its second fiscal quarter and the first six months of its fiscal year.
Prospect Capital Corporation filed its quarterly report on Form 10-Q for the period ended September 30, 2026, disclosing consolidated balance sheet data and portfolio investment values as of that date.
Stoneridge, Inc. filed its Form 10-Q for the quarter ended September 30, 2026 with the Securities and Exchange Commission on November 4, 2026, reporting its financial position following the sale of its Control Devices segment.
Outset Medical, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 4, 2026, reporting financial results for both the three and nine months ended on that date.